News
The recent FDA approval of Aphexda combined with filgrastim improved the collection of stem cells in patients with multiple myeloma. Stem cell transplantation is an important treatment method for ...
Stem cell therapy continues to transform the landscape of modern medicine, with successful interventions across the world ...
Dec 24, 2003 — Double transplantation of autologous stem cells improves overall survival among patients with myeloma, as compared to single transplant, according to results of a randomized trial ...
Stem cell mobilization and transplantation represent pivotal advances in the management of multiple myeloma. This therapeutic approach involves stimulating the release of haematopoietic stem cells ...
The combination therapy is the first FDA approved for the mobilization of hematopoietic stem cells prior to autologous transplantation in patients with multiple myeloma. The FDA approved motixafortide ...
An expert sat down with CURE® and discussed how stem cells are collected before a patient with myeloma undergoes a stem cell transplant. A stem cell transplant is one of the most efficient tools to ...
The FDA has approved the CXCR4 antagonist motixafortide (Aphexda) for use with filgrastim (Neupogen) to mobilize stem cells for autologous transplantation in multiple myeloma, BioLineRx announced on ...
NEPTUNE - In 2020, Julie Zgola swabbed the inside of her cheek. A few years later, that action would save a stranger’s life.
Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window A real-world analysis presented at the American Society of ...
Greyhound Flix's parent company and the non-profit stem cell donor registry DKMS are teaming up for a long-term international ...
CAR T-cell therapy is a type of immunotherapy used to treat multiple myeloma when other therapies have failed. It has improved remission and survival times, but long-term data on safety and success is ...
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma Between January 2002 and March 2005, 269 patients with newly diagnosed MM who achieved disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results